CA2206211A1 - Dispositif de liberation controlee d'une suspension medicamenteuse - Google Patents

Dispositif de liberation controlee d'une suspension medicamenteuse

Info

Publication number
CA2206211A1
CA2206211A1 CA002206211A CA2206211A CA2206211A1 CA 2206211 A1 CA2206211 A1 CA 2206211A1 CA 002206211 A CA002206211 A CA 002206211A CA 2206211 A CA2206211 A CA 2206211A CA 2206211 A1 CA2206211 A1 CA 2206211A1
Authority
CA
Canada
Prior art keywords
delivery device
controlled release
release drug
drug suspension
hydration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002206211A
Other languages
English (en)
Other versions
CA2206211C (fr
Inventor
Gerald S. Rork
James D. Pipkin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck & Co., Inc.
Gerald S. Rork
James D. Pipkin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/363,451 external-priority patent/US5582838A/en
Application filed by Merck & Co., Inc., Gerald S. Rork, James D. Pipkin filed Critical Merck & Co., Inc.
Publication of CA2206211A1 publication Critical patent/CA2206211A1/fr
Application granted granted Critical
Publication of CA2206211C publication Critical patent/CA2206211C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
CA002206211A 1994-12-22 1995-12-18 Dispositif de liberation controlee d'une suspension medicamenteuse Expired - Fee Related CA2206211C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US363,451 1994-12-22
US08/363,451 US5582838A (en) 1994-12-22 1994-12-22 Controlled release drug suspension delivery device
PCT/US1995/016530 WO1996019201A1 (fr) 1994-12-22 1995-12-18 Dispositif de liberation controlee d'une suspension medicamenteuse

Publications (2)

Publication Number Publication Date
CA2206211A1 true CA2206211A1 (fr) 1996-06-27
CA2206211C CA2206211C (fr) 2006-08-08

Family

ID=36791734

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002206211A Expired - Fee Related CA2206211C (fr) 1994-12-22 1995-12-18 Dispositif de liberation controlee d'une suspension medicamenteuse

Country Status (1)

Country Link
CA (1) CA2206211C (fr)

Also Published As

Publication number Publication date
CA2206211C (fr) 2006-08-08

Similar Documents

Publication Publication Date Title
MX9704672A (es) Dispositivo surtidor de suspension de farmaco, de liberacion controlada.
CA2142848A1 (fr) Grains possedant un noyau revetu d'un agent antifongique et d'un polymere
CA2269501A1 (fr) Comprimes a noyau enrobe d'un agent antifongique et d'un polymere
CA2085871A1 (fr) Microcapsule
CA2350061A1 (fr) Nouveau comprime a liberation controlee, methode de production, et formulation multicouche comprenant ledit comprime
CA2301685A1 (fr) Dispositifs d'administration de medicament a degagement prolonge
HUT69397A (en) Process for producing retard composition with diffusive-osmotic release
CA2304110A1 (fr) Comprime de theophylline a liberation prolongee
MX9600858A (es) Nuevas perlas o globulos para liberacion controlada y una preparacion farmaceutica que contiene las mismas.
CA2225096A1 (fr) Mode d'application de revetements liberant un medicament
AU5703090A (en) Process for the preparation of presulphided catalyst; process for the preparation of a sulphided catalyst, and use of said catalyst
CA2315110A1 (fr) Granules a noyau enrobe d'un antifongique et d'un polymere
EP0903226A3 (fr) Plaque lithographique thermosensible, procédé pour sa préparation et méthode de formations d'images
WO1996011054A3 (fr) Procede de preparation de microbilles et microbilles ainsi preparees
CA2206211A1 (fr) Dispositif de liberation controlee d'une suspension medicamenteuse
CA2288482A1 (fr) Sparadrap mince traite avec de la betamethasone et de l'acide hyaluronique pour le traitement du psoriasis, des dermatites et des dermatoses
AU1092095A (en) Intra-uterine ring for the release of an active agent, such as a hormone, and an introducer
IT1275267B (it) Forme farmaceutiche a rilascio modificato di canrenoato di potassio costituite da matrici idrofile rivestite
TH22631A (th) ลูกกลมแบบใหม่สำหรับควบคุมการปล่อยสารและการเตรียมยาที่ประกอบด้วยลูกกลมชนิดเดียวกัน

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed